Structural Basis for Binding and Selectivity of Antimalarial and Anticancer Ethylenediamine Inhibitors to Protein Farnesyltransferase
- 1 February 2009
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 16 (2) , 181-192
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Structure of Protein Geranylgeranyltransferase-I from the Human Pathogen Candida albicans Complexed with a Lipid SubstrateJournal of Biological Chemistry, 2008
- Efficacy, Pharmacokinetics, and Metabolism of Tetrahydroquinoline Inhibitors of Plasmodium falciparum Protein FarnesyltransferaseAntimicrobial Agents and Chemotherapy, 2007
- Resistance mutations at the lipid substrate binding site of Plasmodium falciparum protein farnesyltransferaseMolecular and Biochemical Parasitology, 2007
- Structurally Simple, Potent, Plasmodium Selective Farnesyltransferase Inhibitors That Arrest the Growth of Malaria ParasitesJournal of Medicinal Chemistry, 2006
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- Crystallographic Analysis Reveals that Anticancer Clinical Candidate L-778,123 Inhibits Protein Farnesyltransferase and Geranylgeranyltransferase-I by Different Binding ModesBiochemistry, 2004
- Crystal Structures of the Anticancer Clinical Candidates R115777 (Tipifarnib) and BMS-214662 Complexed with Protein Farnesyltransferase Suggest a Mechanism of FTI SelectivityBiochemistry, 2004
- Refinement of Macromolecular Structures by the Maximum-Likelihood MethodActa Crystallographica Section D Structural Biology, 1997
- SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modelingElectrophoresis, 1997
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994